(Q34563024)

English

Rare uterine cancers

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

Rare uterine cancers (English)

1 reference

Europe PubMed Central

3 August 2017

author name string

Sheetal Acharya

1

1 reference

Europe PubMed Central

3 August 2017

Martee L Hensley

2

1 reference

Europe PubMed Central

3 August 2017

Anthony C Montag

3

1 reference

Europe PubMed Central

3 August 2017

Gini F Fleming

4

1 reference

Europe PubMed Central

3 August 2017

publication date

1 December 2005

1 reference

Europe PubMed Central

3 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

3 August 2017

6

1 reference

Europe PubMed Central

3 August 2017

12

1 reference

Europe PubMed Central

3 August 2017

961-971

1 reference

Europe PubMed Central

3 August 2017

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Two pathogenetic types of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic parameters of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clear-cell and papillary serous cancer: treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular characterization of uterine clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Her-2/neu overexpression and amplification in uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Stage I serous papillary carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninvasive papillary serous carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognosis for papillary serous carcinoma of the endometrium after surgical staging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mesonephroma” of ovary. Tumor of müllerian nature related to the endometrioid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary squamous cell carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine sarcomas: prognostic factors and treatment modalities--study on 209 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine sarcoma: twenty-seven years of experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of endometrial stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial stromal sarcoma: objective response to letrozole

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-grade endometrial stromal sarcoma: hormonal aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormonal treatment of an endometrial stromal nodule followed by local excision

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Myxoid leiomyosarcoma of the uterus. A report of six cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical Resection of Pulmonary and Extrapulmonary Recurrences of Uterine Leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone in the treatment of advanced uterine sarcoma. A phase II trial of the Gynecologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with hydroxyurea, dacarbazine (DTIC), and etoposide in the treatment of uterine leiomyosarcoma: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970463-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(05)70463-0

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34563024&oldid=1555500240"